Author: Andy Gordon

I made my chops as an entrepreneur and investor with over 30 years of experience at building wealth for myself and others. I graduated from the London School of Economics a year after the bicentennial. By the way, this is the same school that produced 34 heads of state including John F. Kennedy… and another 18 Nobel Laureates…

Subscribe to ANDREW's feed.

Crowdfunding Shows Its Strength

Crowdfunding reached the ripe age of four years old earlier this month. It’s come a long way in a relatively short time. And we know much more about it now than we did back then. Last week I gave you five of my top 10 observations about crowdfunding’s past and future. Here are the rest — beginning with a topic that’s particularly relevant to the trying times we’re in… Don’t sweat falling equity prices. A falling market is nothing…

Premium

Winc Sees ‘Massive Opportunity’ Moving Forward

By Andy Gordon on May 21, 2020

Much has changed since we recommended Winc last December. The popular direct-to-consumer wine company was one of the last pre-pandemic recommendations we made. Now lockdowns and quarantines have become our normal. And with so many of us stuck at home, meals have taken center stage in our lives. So it’s…

Crowdfunding Keeps Getting Better Four Years In

By Andy Gordon on May 20, 2020

Crowdfunding celebrated its fourth anniversary last week. The SEC greenlit it on May 16, 2016. A year before Regulation Crowdfunding (better known as Reg. CF) began, the SEC began to allow companies to raise funds under Regulation A+ (Reg. A+). But startups needed considerable money and time to comply with…
Premium

NowRx Facing “Unprecedented” Demand

By Andy Gordon on May 18, 2020

When we first recommended NowRx to you in July 2018, its valuation was $20 million. Last November, we recommended you invest in the company again at a $65 million valuation — a more than 3X increase on your original investment price. We were impressed by its execution and…
Premium

Invest in the Startup That Helps Doctors Make Better Decisions

By Andy Gordon on May 14, 2020

Deal Details Startup: Elemeno Health Security type: Crowd SAFE Discount: 0% Valuation (cap): $12 million Minimum investment: $100 Where to invest: Republic Deadline: September 16, 2020 View Elemeno Health’s latest 2024 funding round analysis on Kingscrowd here. Timing is everything — especially…

New Crowdfunding Rules Bring New Opportunities

By Andy Gordon on May 13, 2020

Economic crises can reveal a lot about established companies. Are they nimble enough to pivot? Can they come up with creative solutions to adapt to a new environment? Was the company prepared for an emergency? Apple and Google were sitting on a pile of cash. They were definitely prepared for…
Premium

Fast Casual Restaurant Startup Fighting For Its Life

By Andy Gordon on May 7, 2020

The COVID-19 pandemic has hit some sectors of the economy like a 7.5 earthquake and other sectors like a gentle rumble. Restaurants, as you’d expect, have been socked the hardest by stay-at-home, business closure and social distancing orders. Many restaurant owners won’t be able to save their businesses. And the…

Can Coronavirus Antibody Tests Save the U.S.?

By Andy Gordon on May 6, 2020

Early Investing Co-Founder Andy Gordon checks in with an expert to figure out what’s going on with coronavirus antibody testing - and how it can help the U.S.
Premium

Startup Investors Finally Have a Tool to Track Their Investments

By Andy Gordon on May 4, 2020

KingsCrowd has launched the first portfolio tracker for startup investments.
Premium

Invest in the Startup That Created the First Saliva Test for Autism

By Andy Gordon on April 30, 2020

A startup has created a saliva test that detects autism so early, it can change the lives of autistic kids.

Video Games Make Billions – and You Can Finally Invest in Them

By Andy Gordon on April 29, 2020

The online video game industry is worth almost $80 billion. And thanks to Republic and Fig, you can now invest in it.

Why Seed-Stage Investing Is Better for You

By Andy Gordon on April 22, 2020

There’s a reason funds prefer investing in startups during their Series A and Series B rounds. But for individuals, it’s no contest. Seed-stage investing is the place to be.
Premium

Webinar: Meet the Founder of Illusio

By Andy Gordon on April 20, 2020

Illusio is a startup that’s developed an augmented reality tool that’s poised to disrupt the plastic surgery industry. And Illusio founder and CEO Ethan Winner is joining us for a special webinar to answer your questions about the company.
Premium

New Recommendation: A Startup Built for Our New Times

By Andy Gordon on April 16, 2020

Investing during a pandemic requires new rules. And this startup checks off all the boxes.

Big Oil’s Problems Are Just Beginning

By Andy Gordon on April 15, 2020

The world’s oil-producing countries reached an agreement to cut production earlier this year. But the deal is too little, too late. And it’s just the beginning of the problems facing the oil industry.
Premium

World Tree Adjusting to COVID-19 Disruptions

By Andy Gordon on April 13, 2020

World Tree explains how it's adjusting to the economic disruption caused by the COVID-19 pandemic.